Fulcrum Therapeutics, Inc. Common Stock
XNAS:FULC
10.59
$10.62 - 291.00
$10.56 - 39.00
$10.55
$11.29
$10.98
$11.05
15.74
2.32
331150
917284.4
59897338.06
Chart
TendieTensor AI Analysis
Company
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
Fundamentals
45
-9.370000
3.014120
100
BBG00DDY1RK9
BBG00DDY1RM7
54.09M
54.12M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own FULC. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.